ALEC Alector, Inc. Stock Quote

ALEC [NASD]

Index	-	P/E	-	EPS (ttm)	-2.44	Insider Own	0.30%	Shs Outstand	79.01M	Perf Week	2.68%
Market Cap	1.49B	Forward P/E	-	EPS next Y	-2.61	Insider Trans	-44.70%	Shs Float	69.09M	Perf Month	-14.37%
Income	-190.20M	PEG	-	EPS next Q	-0.68	Inst Own	75.50%	Short Float	8.41%	Perf Quarter	0.39%
Sales	21.10M	P/S	70.48	EPS this Y	-43.30%	Inst Trans	-3.63%	Short Ratio	8.73	Perf Half Y	74.93%
Book/sh	3.39	P/B	5.31	EPS next Y	10.00%	ROA	-34.40%	Target Price	-	Perf Year	-28.34%
Cash/sh	5.00	P/C	3.60	EPS next 5Y	-	ROE	-57.40%	52W Range	9.12 - 34.89	Perf YTD	18.97%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-73.00%	52W High	-48.41%	Beta	-
Dividend %	-	Quick Ratio	6.20	Sales past 5Y	-	Gross Margin	-	52W Low	97.37%	ATR	1.40
Employees	171	Current Ratio	6.20	Sales Q/Q	-18.30%	Oper. Margin	-	RSI (14)	48.70	Volatility	6.06% 8.43%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-47.00%	Profit Margin	-	Rel Volume	0.76	Prev Close	17.85
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	665.43K	Price	18.00
Recom	1.60	SMA20	-2.06%	SMA50	-3.08%	SMA200	15.36%	Volume	504,107	Change	0.84%

Jan-15-21

Resumed

BofA Securities

Buy

$35

Jun-24-20

Initiated

H.C. Wainwright

Buy

$41

Apr-28-20

Initiated

Goldman

Buy

$32

Mar-06-20

Initiated

Citigroup

Buy

$40

Feb-27-20

Initiated

Barclays

Overweight

$36

Feb-19-20

Initiated

Stifel

Buy

$44

Nov-21-19

Initiated

BTIG Research

Buy

$28

Mar-04-19

Initiated

SVB Leerink

Outperform

Mar-04-19

Initiated

Morgan Stanley

Overweight

$27

Mar-04-19

Initiated

BofA/Merrill

Buy

$26

Mar-04-19

Initiated

Barclays

Overweight

$27

Mar-30-21 01:23PM	Replay: Investing in Alzheimers Treatment Jupiter Orphan Therapeutics CEO Joins Fireside Chat IPO-Edge.com
Mar-25-21 04:05PM	Alector to Present at Stifels 3rd Annual CNS Day GlobeNewswire -6.64%
Mar-23-21 01:53PM	Investing in Alzheimers Treatment: Join Jupiter Orphan Therapeutics for Fireside Chat March 30 IPO-Edge.com -11.02%
Mar-04-21 04:05PM	Alector to Present at the Barclays Global Healthcare Conference GlobeNewswire
Feb-28-21 01:36AM	Reflecting on Alector's (NASDAQ:ALEC) Share Price Returns Over The Last Year Simply Wall St.
Feb-25-21 04:05PM	Alector Reports 2020 Fourth Quarter and Full Year Financial Results and Provides Business Update GlobeNewswire -6.97%
Jan-25-21 08:30AM	Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL002 in Individuals with Early Alzheimers Disease GlobeNewswire +9.40%
Jan-20-21 04:15PM	Alector Announces Departure of Chief Business Officer GlobeNewswire
Jan-07-21 04:05PM	Alector Provides 2021 Corporate Portfolio Update GlobeNewswire
Dec-29-20 11:42PM	Are Insiders Buying Alector, Inc. (NASDAQ:ALEC) Stock? Simply Wall St.
Dec-11-20 08:56AM	Is Alector (ALEC) a Smart Long-term Buy? Insider Monkey
Nov-12-20 11:18AM	Does Good News About Biogen's Alzheimer's Drug Mean Bad News for Rivals? Motley Fool +5.22%
Nov-11-20 04:05PM	Alector to Present at the Stifel 2020 Virtual Healthcare Conference GlobeNewswire
Nov-10-20 06:45PM	Alector (ALEC) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:05PM	Alector Reports Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Nov-09-20 05:30AM	We Think Alector (NASDAQ:ALEC) Can Afford To Drive Business Growth Simply Wall St. +5.63%
Nov-03-20 12:30PM	Analysts Estimate Alector (ALEC) to Report a Decline in Earnings: What to Look Out for Zacks
Nov-02-20 07:44AM	Alector Provides Update on Arbitration Proceedings with Dr. Asa Abeliovich GlobeNewswire
Oct-22-20 04:05PM	Alector to Highlight Early-Stage Cancer Programs at Upcoming Scientific Forums GlobeNewswire
Oct-06-20 08:54AM	Alector (ALEC) Surges: Stock Moves 6.9% Higher Zacks
Sep-24-20 11:46AM	25 Easiest Trivia Questions For Seniors With Dementia Insider Monkey
Sep-16-20 03:23PM	Hedge Funds Are Piling Into Alector, Inc. (ALEC) Insider Monkey
Sep-13-20 08:53AM	Alector's (NASDAQ:ALEC) Shareholders Are Down 32% On Their Shares Simply Wall St.
Sep-03-20 04:05PM	Alector to Participate at Virtual Investor Conferences in September GlobeNewswire
Aug-11-20 05:55PM	Alector (ALEC) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:05PM	Alector Reports Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Aug-04-20 08:30AM	Alector to Present at the BTIG Virtual Biotechnology Conference 2020 GlobeNewswire
Aug-03-20 12:31PM	Analysts Estimate Alector (ALEC) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-29-20 01:00PM	Why Alector Is Tumbling 28.7% Today Motley Fool -23.57%
07:32AM	The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More Benzinga
Jul-28-20 06:00PM	Alector Announces Promising Preliminary Data from AL001 Phase 1b and Phase 2 Open-Label Long-Term Dosing Study of People with Frontotemporal Dementia GlobeNewswire -8.69%
Jul-24-20 06:12PM	13Ds Filings Barrons.com
08:30AM	Alector Doses First Patient in Pivotal Phase 3 INFRONT-3 Trial Evaluating AL001 in Patients with Frontotemporal Dementia GlobeNewswire
Jul-21-20 05:00PM	Alector to Present Data from the AL001 Phase 2 Open-Label Study in Frontotemporal Dementia at the 2020 Alzheimers Association International Conference GlobeNewswire -9.83%
05:00PM	Alector to Present Data from the AL001 Phase 2 Open-Label Study in Frontotemporal Dementia at the 2020 Alzheimers Association International Conference GlobeNewswire
Jul-15-20 07:31AM	Should You Take Comfort From Insider Transactions At Alector, Inc. (NASDAQ:ALEC)? Simply Wall St.
Jun-28-20 07:16PM	Hedge Funds Keep Buying Alector, Inc. (ALEC) Insider Monkey
Jun-25-20 09:00AM	Alector Announces Publication of Preclinical and Phase 1 Data Validating Potential of AL002, a TREM2 Activating Antibody for the Treatment of Alzheimers Disease, in The Journal of Experimental Medicine GlobeNewswire
Jun-12-20 07:00PM	NortonLifeLock and Bancorp See Activist Actions Barrons.com
Jun-03-20 04:01PM	Alector to Present at the Goldman Sachs 41st Annual Global Healthcare Conference GlobeNewswire -7.11%
May-16-20 08:05AM	Analysts Have Made A Financial Statement On Alector, Inc.'s (NASDAQ:ALEC) First-Quarter Report Simply Wall St.
May-13-20 09:25AM	Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates Zacks +6.48%
08:00AM	Alector Reports 2020 First Quarter Financial Results and Business Highlights GlobeNewswire
May-07-20 08:30AM	Alector to Present at the Bank of America Securities Virtual Health Care Conference GlobeNewswire
May-04-20 08:20AM	Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 30% (NEWS-PORTAL) TipRanks +6.12%
May-03-20 07:00AM	Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 30% TipRanks
Apr-02-20 11:30AM	Is Alector (ALEC) Outperforming Other Medical Stocks This Year? Zacks
Mar-31-20 10:34AM	Growth Investors: Industry Analysts Just Upgraded Their Alector, Inc. (NASDAQ:ALEC) Revenue Forecasts By 36% Simply Wall St.
Mar-26-20 06:11AM	Earnings Beat: Alector, Inc. (NASDAQ:ALEC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts Simply Wall St. +5.54%
Mar-25-20 05:00PM	Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China GlobeNewswire
Mar-24-20 05:25PM	Alector (ALEC) Reports Q4 Loss, Misses Revenue Estimates Zacks
04:05PM	Alector Reports 2019 Fourth Quarter and Full Year Financial Results and Business Highlights GlobeNewswire
Mar-23-20 08:30AM	Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors GlobeNewswire -18.76%
Mar-17-20 12:30PM	Alector (ALEC) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks +21.57%
12:00PM	What Makes Alector (ALEC) a New Buy Stock Zacks
11:30AM	Is Alector (ALEC) Outperforming Other Medical Stocks This Year? Zacks
Mar-11-20 09:53AM	Are Options Traders Betting on a Big Move in Alector (ALEC) Stock? Zacks -7.77%
Mar-06-20 07:25PM	Dave & Busters, International Flavors, Trinity Industries, 13D Filings Barrons.com
Feb-28-20 08:51AM	Why Alector (ALEC) Could Be Positioned for a Surge Zacks +6.10%
Feb-24-20 08:30AM	Alector to Present at the Cowen 40th Annual Health Care Conference GlobeNewswire -10.24%
Feb-06-20 07:47AM	The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs Benzinga
Feb-05-20 08:00AM	Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia GlobeNewswire +11.70%
07:21AM	David Wehner Is The Independent Director of Alector, Inc. (NASDAQ:ALEC) And They Just Spent US$500k On Shares Simply Wall St.
Feb-03-20 06:00PM	Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire
Jan-31-20 09:09AM	The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO Benzinga
08:00AM	Alector Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Public Offering GlobeNewswire
Jan-29-20 09:42PM	Alector Announces Upsizing and Pricing of Public Offering GlobeNewswire +5.49%
Jan-28-20 08:30AM	Alector Announces Initiation of Phase 1b Study of AL003 in Alzheimers Disease Patients GlobeNewswire
Jan-27-20 04:05PM	Alector Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-17-20 08:45PM	13D Filings Barrons.com +7.49%
Jan-08-20 08:30AM	Alector to Present at the J.P. Morgan 38th Annual Healthcare Conference GlobeNewswire +9.96%
Jan-06-20 08:30AM	Alector Initiates First-in-Human Dosing in Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases GlobeNewswire
Dec-27-19 02:57PM	Insiders Roundup: Nike, Eastman Kodak GuruFocus.com
Dec-20-19 08:30AM	Alector Added to the NASDAQ Biotechnology Index GlobeNewswire
Dec-13-19 06:30AM	Alector Appoints Dr. Richard Scheller, Lasker Prize Awarded Scientist, and Dr. Thomas Südhof, Nobel Laureate as Co-Chairs of its Strategic Portfolio Advice and Review Committee GlobeNewswire
06:28AM	Alector Showcases Progress in Immuno-Neurology Clinical Programs and Research Portfolio at R&D Day GlobeNewswire
Dec-12-19 07:08PM	Hedge Funds Have Never Been More Bullish On Alector, Inc. (ALEC) Insider Monkey
Dec-11-19 04:05PM	Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer GlobeNewswire
Dec-06-19 04:30PM	Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimers Disease (CTAD) Meeting GlobeNewswire
07:39AM	The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend Benzinga
Dec-05-19 04:22PM	Alector Announces FDA Fast Track Designation Granted to AL001 for the Treatment of Patients with Frontotemporal Dementia GlobeNewswire
Dec-04-19 09:15AM	Alector to Host R&D Day on December 13, 2019 GlobeNewswire
Nov-14-19 08:30AM	Alector to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire
Nov-12-19 04:05PM	Alector Reports Recent Business Highlights and Third Quarter 2019 Financial Results GlobeNewswire
Nov-11-19 09:28AM	4 Biotech Stocks That Could Keep Beating Wall Street Zacks
Oct-28-19 07:46PM	Hedge Funds Have Never Been This Bullish On Alector, Inc. (ALEC) Insider Monkey
Sep-23-19 01:22PM	AC Immune to Earn Milestone From Lilly for Alzheimer's Drug Zacks
Sep-20-19 10:02AM	6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day Zacks +7.68%
Sep-19-19 06:56AM	Alector, Inc.'s (NASDAQ:ALEC) Single Biggest Risk For Investors Simply Wall St.
Sep-09-19 08:00AM	Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia GlobeNewswire
Sep-03-19 04:10PM	Alector to Present at 17th Annual Morgan Stanley Global Healthcare Conference GlobeNewswire -5.65%
Aug-12-19 04:10PM	Alector Reports Recent Business Highlights and Second Quarter 2019 Financial Results GlobeNewswire
09:00AM	Alector Announces the Addition of Kristine Yaffe, M.D., to the Board of Directors GlobeNewswire
Jul-18-19 10:26AM	AC Immune Initiates Phase I Study for Alzheimer's Disease Zacks
Jul-17-19 04:05PM	Alector Announces Data from On-going Phase 1b Trial Demonstrating that AL001 Reverses Progranulin Deficiency in Frontotemporal Dementia Patients GlobeNewswire
Jul-11-19 06:30AM	Alector Announces Upcoming Presentations at 2019 Alzheimer's Association International Conference GlobeNewswire
Jun-26-19 09:04PM	Hedge Funds Have Never Been This Bullish On Alector, Inc. (ALEC) Insider Monkey
Jun-14-19 12:03PM	Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures Investor's Business Daily
May-13-19 04:26PM	Alector: 1Q Earnings Snapshot Associated Press
04:05PM	Alector Reports Recent Business Highlights and First Quarter 2019 Financial Results GlobeNewswire

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies. The company was founded in 2013 and is headquartered in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Paul Robert	Chief Medical Officer	Apr 07	Option Exercise	9.60	22,300	214,186	236,019	Apr 08 08:18 PM
Paul Robert	Chief Medical Officer	Apr 07	Sale	19.20	22,300	428,050	213,719	Apr 08 08:18 PM
Paul Robert	Chief Medical Officer	Mar 23	Option Exercise	8.16	13,800	112,608	227,519	Mar 24 04:36 PM
Paul Robert	Chief Medical Officer	Mar 23	Sale	22.21	13,800	306,498	213,719	Mar 24 04:36 PM
Paul Robert	Chief Medical Officer	Mar 22	Option Exercise	8.16	30,000	244,800	243,719	Mar 24 04:36 PM
Paul Robert	Chief Medical Officer	Mar 22	Sale	22.98	30,000	689,376	213,719	Mar 24 04:36 PM
Paul Robert	Chief Medical Officer	Mar 09	Option Exercise	8.38	19,175	160,592	232,894	Mar 10 06:29 PM
Paul Robert	Chief Medical Officer	Mar 09	Sale	18.12	19,175	347,405	213,719	Mar 10 06:29 PM
Paul Robert	Chief Medical Officer	Feb 09	Option Exercise	8.38	19,175	160,594	232,894	Feb 11 05:08 PM
Paul Robert	Chief Medical Officer	Feb 09	Sale	20.81	19,175	399,055	213,719	Feb 11 05:08 PM
Paul Robert	Chief Medical Officer	Jan 26	Option Exercise	8.46	27,308	231,082	241,027	Jan 27 06:53 PM
Paul Robert	Chief Medical Officer	Jan 26	Sale	18.00	27,308	491,544	213,719	Jan 27 06:53 PM
Paul Robert	Chief Medical Officer	Jan 25	Option Exercise	8.30	30,000	248,926	243,719	Jan 27 06:53 PM
Paul Robert	Chief Medical Officer	Jan 25	Sale	18.01	30,000	540,225	213,719	Jan 27 06:53 PM
Paul Robert	Chief Medical Officer	Jan 20	Option Exercise	8.64	8,567	74,031	222,286	Jan 21 06:46 PM
Paul Robert	Chief Medical Officer	Jan 20	Sale	18.00	8,567	154,211	213,719	Jan 21 06:46 PM
Paul Robert	Chief Medical Officer	Jan 19	Option Exercise	8.30	30,000	248,924	243,719	Jan 21 06:46 PM
Paul Robert	Chief Medical Officer	Jan 19	Sale	18.12	30,000	543,552	213,719	Jan 21 06:46 PM
Paul Robert	Chief Medical Officer	Jul 15	Sale	22.96	10,000	229,642	213,719	Jul 17 04:43 PM
MCGUIRE TERRANCE	Director	Jun 23	Sale	31.54	4,377	138,063	12,853,817	Jun 25 05:53 PM
Polaris Venture Management Co.	10% Owner	Jun 23	Sale	31.54	4,377	138,063	12,853,817	Jun 25 05:47 PM
Paul Robert	Chief Medical Officer	Jun 15	Sale	29.61	10,000	296,137	223,719	Jun 17 04:21 PM
Yu Calvin	Vice President, Finance	Jun 03	Sale	31.26	1,343	41,981	110,686	Jun 05 04:40 PM
King Robert	Chief Development Officer	May 15	Sale	27.00	15,000	404,958	477,317	May 19 05:23 PM
Paul Robert	Chief Medical Officer	May 15	Sale	27.00	10,000	270,026	233,719	May 19 05:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience